Undernutrition as a risk factor for tuberculosis disease.
Journal
The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747
Informations de publication
Date de publication:
11 Jun 2024
11 Jun 2024
Historique:
medline:
11
6
2024
pubmed:
11
6
2024
entrez:
11
6
2024
Statut:
epublish
Résumé
Tuberculosis (TB) is a leading cause of mortality due to an infectious disease, with an estimated 1.6 million deaths due to TB in 2022. Approximately 25% of the global population has TB infection, giving rise to 10.6 million episodes of TB disease in 2022. Undernutrition is a key risk factor for TB and was linked to an estimated 2.2 million TB episodes in 2022, as outlined in the World Health Organization (WHO) Global Tuberculosis Report. To determine the prognostic value of undernutrition in the general population of adults, adolescents, and children for predicting tuberculosis disease over any time period. We searched the literature databases MEDLINE (via PubMed) and WHO Global Index Medicus, as well as the WHO International Clinical Trials Registry Platform (ICTRP) on 3 May 2023 (date of last search for all databases). We placed no restrictions on the language of publication. We included retrospective and prospective cohort studies, irrespective of publication status or language. The target population comprised adults, adolescents, and children from diverse settings, encompassing outpatient and inpatient cohorts, with varying comorbidities and risk of exposure to tuberculosis. We used standard Cochrane methodology and the Quality In Prognosis Studies (QUIPS) tool to assess the risk of bias of the studies. Prognostic factors included undernutrition, defined as wasting, stunting, and underweight, with specific measures such as body mass index (BMI) less than two standard deviations below the median for children and adolescents and low BMI scores (< 18.5) for adults and adolescents. Prognostication occurred at enrolment/baseline. The primary outcome was the incidence of TB disease. The secondary outcome was recurrent TB disease. We performed a random-effects meta-analysis for the adjusted hazard ratios (HR), risk ratios (RR), or odds ratios (OR), employing the restricted maximum likelihood estimation. We rated the certainty of the evidence using the GRADE approach. We included 51 cohort studies with over 27 million participants from the six WHO regions. Sixteen large population-based studies were conducted in China, Singapore, South Korea, and the USA, and 25 studies focused on people living with HIV, which were mainly conducted in the African region. Most studies were in adults, four in children, and three in children and adults. Undernutrition as an exposure was usually defined according to standard criteria; however, the diagnosis of TB did not include a confirmatory culture or molecular diagnosis using a WHO-approved rapid diagnostic test in eight studies. The median follow-up time was 3.5 years, and the studies primarily reported an adjusted hazard ratio from a multivariable Cox-proportional hazard model. Hazard ratios (HR) The HR estimates represent the highest certainty of the evidence, explored through sensitivity analyses and excluding studies at high risk of bias. We present 95% confidence intervals (CI) and prediction intervals, which present between-study heterogeneity represented in a measurement of the variability of effect sizes (i.e. the interval within which the effect size of a new study would fall considering the same population of studies included in the meta-analysis). Undernutrition may increase the risk of TB disease (HR 2.23, 95% CI 1.83 to 2.72; prediction interval 0.98 to 5.05; 23 studies; 2,883,266 participants). The certainty of the evidence is low due to a moderate risk of bias across studies and inconsistency. When stratified by follow-up time, the results are more consistent across < 10 years follow-up (HR 2.02, 95% CI 1.74 to 2.34; prediction interval 1.20 to 3.39; 22 studies; 2,869,077 participants). This results in a moderate certainty of evidence due to a moderate risk of bias across studies. However, at 10 or more years of follow-up, we found only one study with a wider CI and higher HR (HR 12.43, 95% CI 5.74 to 26.91; 14,189 participants). The certainty of the evidence is low due to the moderate risk of bias and indirectness. Odds ratio (OR) Undernutrition may increase the odds of TB disease, but the results are uncertain (OR 1.56, 95% CI 1.13 to 2.17; prediction interval 0.61 to 3.99; 8 studies; 173,497 participants). Stratification by follow-up was not possible as all studies had a follow-up of < 10 years. The certainty of the evidence is very low due to the high risk of bias and inconsistency. Contour-enhanced funnel plots were not reported due to the few studies included. Risk ratio (RR) Undernutrition may increase the risk of TB disease (RR 1.95, 95% CI 1.72 to 2.20; prediction interval 1.49 to 2.55; 4 studies; 1,475,867 participants). Stratification by follow-up was not possible as all studies had a follow-up of < 10 years. The certainty of the evidence is low due to the high risk of bias. Contour-enhanced funnel plots were not reported due to the few studies included. Undernutrition probably increases the risk of TB two-fold in the short term (< 10 years) and may also increase the risk in the long term (> 10 years). Policies targeted towards the reduction of the burden of undernutrition are not only needed to alleviate human suffering due to undernutrition and its many adverse consequences, but are also an important part of the critical measures for ending the TB epidemic by 2030. Large population-based cohorts, including those derived from high-quality national registries of exposures (undernutrition) and outcomes (TB disease), are needed to provide high-certainty estimates of this risk across different settings and populations, including low and middle-income countries from different WHO regions. Moreover, studies including children and adolescents and state-of-the-art methods for diagnosing TB would provide more up-to-date information relevant to practice and policy. World Health Organization (203256442). PROSPERO registration: CRD42023408807 Protocol: https://doi.org/10.1002/14651858.CD015890.
Sections du résumé
BACKGROUND
BACKGROUND
Tuberculosis (TB) is a leading cause of mortality due to an infectious disease, with an estimated 1.6 million deaths due to TB in 2022. Approximately 25% of the global population has TB infection, giving rise to 10.6 million episodes of TB disease in 2022. Undernutrition is a key risk factor for TB and was linked to an estimated 2.2 million TB episodes in 2022, as outlined in the World Health Organization (WHO) Global Tuberculosis Report.
OBJECTIVES
OBJECTIVE
To determine the prognostic value of undernutrition in the general population of adults, adolescents, and children for predicting tuberculosis disease over any time period.
SEARCH METHODS
METHODS
We searched the literature databases MEDLINE (via PubMed) and WHO Global Index Medicus, as well as the WHO International Clinical Trials Registry Platform (ICTRP) on 3 May 2023 (date of last search for all databases). We placed no restrictions on the language of publication.
SELECTION CRITERIA
METHODS
We included retrospective and prospective cohort studies, irrespective of publication status or language. The target population comprised adults, adolescents, and children from diverse settings, encompassing outpatient and inpatient cohorts, with varying comorbidities and risk of exposure to tuberculosis.
DATA COLLECTION AND ANALYSIS
METHODS
We used standard Cochrane methodology and the Quality In Prognosis Studies (QUIPS) tool to assess the risk of bias of the studies. Prognostic factors included undernutrition, defined as wasting, stunting, and underweight, with specific measures such as body mass index (BMI) less than two standard deviations below the median for children and adolescents and low BMI scores (< 18.5) for adults and adolescents. Prognostication occurred at enrolment/baseline. The primary outcome was the incidence of TB disease. The secondary outcome was recurrent TB disease. We performed a random-effects meta-analysis for the adjusted hazard ratios (HR), risk ratios (RR), or odds ratios (OR), employing the restricted maximum likelihood estimation. We rated the certainty of the evidence using the GRADE approach.
MAIN RESULTS
RESULTS
We included 51 cohort studies with over 27 million participants from the six WHO regions. Sixteen large population-based studies were conducted in China, Singapore, South Korea, and the USA, and 25 studies focused on people living with HIV, which were mainly conducted in the African region. Most studies were in adults, four in children, and three in children and adults. Undernutrition as an exposure was usually defined according to standard criteria; however, the diagnosis of TB did not include a confirmatory culture or molecular diagnosis using a WHO-approved rapid diagnostic test in eight studies. The median follow-up time was 3.5 years, and the studies primarily reported an adjusted hazard ratio from a multivariable Cox-proportional hazard model. Hazard ratios (HR) The HR estimates represent the highest certainty of the evidence, explored through sensitivity analyses and excluding studies at high risk of bias. We present 95% confidence intervals (CI) and prediction intervals, which present between-study heterogeneity represented in a measurement of the variability of effect sizes (i.e. the interval within which the effect size of a new study would fall considering the same population of studies included in the meta-analysis). Undernutrition may increase the risk of TB disease (HR 2.23, 95% CI 1.83 to 2.72; prediction interval 0.98 to 5.05; 23 studies; 2,883,266 participants). The certainty of the evidence is low due to a moderate risk of bias across studies and inconsistency. When stratified by follow-up time, the results are more consistent across < 10 years follow-up (HR 2.02, 95% CI 1.74 to 2.34; prediction interval 1.20 to 3.39; 22 studies; 2,869,077 participants). This results in a moderate certainty of evidence due to a moderate risk of bias across studies. However, at 10 or more years of follow-up, we found only one study with a wider CI and higher HR (HR 12.43, 95% CI 5.74 to 26.91; 14,189 participants). The certainty of the evidence is low due to the moderate risk of bias and indirectness. Odds ratio (OR) Undernutrition may increase the odds of TB disease, but the results are uncertain (OR 1.56, 95% CI 1.13 to 2.17; prediction interval 0.61 to 3.99; 8 studies; 173,497 participants). Stratification by follow-up was not possible as all studies had a follow-up of < 10 years. The certainty of the evidence is very low due to the high risk of bias and inconsistency. Contour-enhanced funnel plots were not reported due to the few studies included. Risk ratio (RR) Undernutrition may increase the risk of TB disease (RR 1.95, 95% CI 1.72 to 2.20; prediction interval 1.49 to 2.55; 4 studies; 1,475,867 participants). Stratification by follow-up was not possible as all studies had a follow-up of < 10 years. The certainty of the evidence is low due to the high risk of bias. Contour-enhanced funnel plots were not reported due to the few studies included.
AUTHORS' CONCLUSIONS
CONCLUSIONS
Undernutrition probably increases the risk of TB two-fold in the short term (< 10 years) and may also increase the risk in the long term (> 10 years). Policies targeted towards the reduction of the burden of undernutrition are not only needed to alleviate human suffering due to undernutrition and its many adverse consequences, but are also an important part of the critical measures for ending the TB epidemic by 2030. Large population-based cohorts, including those derived from high-quality national registries of exposures (undernutrition) and outcomes (TB disease), are needed to provide high-certainty estimates of this risk across different settings and populations, including low and middle-income countries from different WHO regions. Moreover, studies including children and adolescents and state-of-the-art methods for diagnosing TB would provide more up-to-date information relevant to practice and policy.
FUNDING
BACKGROUND
World Health Organization (203256442).
REGISTRATION
BACKGROUND
PROSPERO registration: CRD42023408807 Protocol: https://doi.org/10.1002/14651858.CD015890.
Identifiants
pubmed: 38860538
doi: 10.1002/14651858.CD015890.pub2
doi:
Types de publication
Journal Article
Systematic Review
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
CD015890Informations de copyright
Copyright © 2024 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.
Références
World Health Organization. Global Tuberculosis Report 2023. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023 (accessed 8 December 2023).
CDC. Core Curriculum on Tuberculosis: What the clinician should know. https://www.cdc.gov/tb/education/corecurr/index.htm (accessed 21 April 2023).
Brett K, Dulong C, Severn M. Prevention of Tuberculosis: A Review of Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health 2020. pubmed.ncbi.nlm.nih.gov/33048484/. [PMID: 33048484]
pubmed: 33048484
Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. American Journal of Public Health 2011;101(4):654-62. [DOI: 10.2105/AJPH.2010.199505]
World Health Organization. Tuberculosis and vulnerable populations. https://www.who.int/europe/news-room/fact-sheets/item/tuberculosis-and-vulnerable-populations (accessed 7 July 2023).
Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Tropical Medicine & International Health 2018;23(10):1058-70. [PMID: 30062731]
pubmed: 30062731
Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, Lönnroth K, Rehm J. Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. European Respiratory Journal 2017;50(1):1700216. [PMID: 28705945]
pubmed: 28705945
Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. International Journal of Epidemiology 2010;39(1):149-55. [PMID: 19820104]
pubmed: 19820104
Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. The Lancet 2010;375:9728. [DOI: 10.1016/S0140-6736(10)60483-7]
Siddalingaiah N, Chawla K, Nagaraja SB, Hazra D. Risk factors for the development of tuberculosis among the pediatric population: a systematic review and meta-analysis. European Journal of Pediatrics 2023;182(7):3007-19. [DOI: 10.1007/s00431-023-04988-0]
Global Nutrition Report. 2020 Global Nutrition Report: Action on equity to end malnutrition. https://globalnutritionreport.org/reports/2020-global-nutrition-report/ (accessed 21 April 2023).
UNICEF-WHO-The World Bank: Joint Child Malnutrition Estimates (JME) – Levels and Trends – 2023 edition. Levels and trends in child malnutrition: key findings of the 2021 edition of the joint child malnutrition estimates. data.unicef.org/resources/jme-report-2023/ (accessed 20 September 2023).
NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. The Lancet 2017;390:2627-42. [DOI: 10.1016/ S0140-6736(17)32129-3]
The State of Food Security and Nutrition in the World 2023. https://www.fao.org/documents/card/en?details=cc3017en (accessed 18 April 2024).
Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, et al. Time since infection and risks of future disease for individuals with Mycobacterium tuberculosis infection in the United States. Epidemiology 2021;1:70-8. [DOI: 10.1097/EDE.0000000000001271]
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of tuberculosis in adults and children. Clinical Infectious Diseases 2017;64(2):111-5. [DOI: 10.1093/cid/ciw778]
World Health Organization (editors). WHO operational handbook on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 2021 update. https://www.who.int/publications/i/item/9789240030589 2021.
World Health Organization (Editors). WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents. https://www.who.int/publications/i/item/9789240046764.
Vega V, Rodríguez S, Van der Stuyft P, Seas C, Otero L. Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections. Thorax 2021;76:494-502.
WHO. WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease. https://www.who.int/publications/i/item/9789240022676 (Accessed 10 April 2024).
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. [DOI: 10.1136/bmj.n71]
World Health Organization. WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years. https://iris.who.int/bitstream/handle/10665/376075/9789240082830-eng.pdf?sequence=1 (accessed 31 May 2024).
Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLOS One 2017;12(11):e0187967. [PMID: 29161276]
pubmed: 29161276
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLOS Medicine 2008;5(7):e152. [PMID: 18630984]
pubmed: 18630984
Obels I, Ninsiima S, Critchley JA, Huangfu P. Tuberculosis risk among people with diabetes mellitus in Sub-Saharan Africa: a systematic review. Tropical Medicine & International Health 2022;27(4):369-86. [PMID: 35146851]
pubmed: 35146851
Adam GP, Paynter R. Development of literature search strategies for evidence syntheses: pros and cons of incorporating text mining tools and objective approaches. BMJ Evidence-Based Medicine 2023;28:137-9.
Edwards LB, Livesay VT, Acquaviva FA, Palmer CE. Height, weight, tuberculous infection, and tuberculous disease. Archives of Environmental Health 1971;22(1):106-12. [DOI: 10.1080/00039896.1971.10665820]
Palmer CE, Jablon S, Edwards PQ. Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build. American Review of Tuberculosis 1957;76(4):517-39. [DOI: 10.1164/artpd.1957.76.4.517]
Ou SM, Liu CJ, Teng CJ, Lin YT, Chang YS, Chiang SC, et al. Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: a nationwide population-based study in Taiwan. Transplant Infectious Disease 2012;14(5):502-9. [DOI: 10.1111/j.1399-3062.2012.00737.x]
Rungruanghiranya S, Ekpanyaskul C, Jirasiritum S, Nilthong C, Pipatpanawong K, Mavichak V. Tuberculosis in Thai renal transplant recipients: a 15-year experience. Transplantation Proceedings 2008;40(7):2376-9. [DOI: 10.1016/j.transproceed.2008.07.034]
Covidence. Melbourne, Australia: Veritas Health Innovation, accessed 18 September 2023. Available at covidence.org.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLOS Medicine 2014;11(10):e1001744. [DOI: 10.1371/journal.pmed.1001744]
Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ 2019;364:k4597. [DOI: 10.1136/bmj.k4597]
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Annals of Internal Medicine 2013;158(4):280-286.
Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326(7382):219. [DOI: 10.1136/bmj.326.7382.219]
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34. [PMID: 9921604]
pubmed: 9921604
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16. [DOI: 10.1186/1745-6215-8-16]
Peat G, Riley RD, Croft P, Morley KI, Kyzas PA, Moons KG. Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols. PLOS Medicine 2014;11(7):e1001671. [DOI: 10.1371/journal.pmed.1001671]
Stata 18. StataCorp LLC, 2023.
Debray TP, Moons KG, Riley RD. Detecting small‐study effects and funnel plot asymmetry in meta‐analysis of survival data: a comparison of new and existing tests. Research Synthesis Methods 2018;9(1):41-50.
Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011;342:d549. [DOI: 10.1136/bmj.d549]
McKenzie JE, Brennan SE. Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Foroutan F, Guyatt G, Zuk V, Vandvik PO, Alba AC, Mustafa R, et al. GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. Journal of Clinical Epidemiology 2020;121:62-70. [PMID: 31982539]
pubmed: 31982539
Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ 2015;350:h870. [DOI: 10.1136/bmj.h870]
Cegielski JP, Arab L, Cornoni-Huntley J. Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992. American Journal of Epidemiology 2012;176(5):409-22. [DOI: 10.1093/aje/kws007]
Dembélé M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, et al. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. International Journal of Tuberculosis and Lung Disease 2010;14(3):318-23.
Gatechompol S, Sophonphan J, Ubolyam S, Avihingsanon A, van Leth F, Cobelens F, et al. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model. BMC Infectious Diseases 2022;22(1):346. [DOI: 10.1186/s12879-022-07332-3]
Morán-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM. Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. International Journal of Tuberculosis and Lung Disease 2010;14(9):1112-9.
Pealing L, Wing K, Mathur R, Prieto-Merino D, Smeeth L, Moore DA. Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMC Medicine 2015;13:135. [DOI: 10.1186/s12916-015-0381-9]
Soh AZ, Chee CBE, Wang YT, Yuan JM, Koh WP. Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort. International Journal of Tuberculosis and Lung Disease 2019;23(12):1277-82. [DOI: 10.5588/ijtld.19.0094]
Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clinical Infectious Diseases 2012;54(6):818-25. [DOI: 10.1093/cid/cir939]
Chan-Yeung M, Dai DL, Cheung AH, Chan FH, Kam KM, Tam CM, et al. Tuberculin skin test reaction and body mass index in old age home residents in Hong Kong. Journal of the American Geriatrics Society 2007;55(10):1592-7. [DOI: 10.1111/j.1532-5415.2007.01316.x]
Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G, et al. Lower risk of tuberculosis in obesity. Archives of Internal Medicine 2007;167(12):1297-304. [DOI: 10.1001/archinte.167.12.1297]
Lin HH, Wu CY, Wang CH, Fu H, Lönnroth K, Chang YC, et al. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clinical Infectious Diseases 2018;66(5):699-705. [DOI: 10.1093/cid/cix852]
Maro I, Lahey T, MacKenzie T, Mtei L, Bakari M, Matee M, et al. Low BMI and falling BMI predict HIV-associated tuberculosis: a prospective study in Tanzania. International Journal of Tuberculosis and Lung Disease 2010;14(11):1447-53.
Tiruneh G, Getahun A, Adeba E. Assessing the impact of isoniazid preventive therapy (IPT) on tuberculosis incidence and predictors of tuberculosis among adult patients enrolled on ART in Nekemte Town, Western Ethiopia: a retrospective cohort study. Interdisciplinary Perspectives on Infectious Diseases 2019;2019:1413427. [DOI: 10.1155/2019/1413427]
Benjumea-Bedoya D, Marín DM, Robledo J, Barrera LF, López L, Del Corral H, et al. Risk of infection and disease progression in children exposed to tuberculosis at home, Colombia. Colombia Medica (Cali, Colombia) 2019;50(4):261-74. [DOI: 10.25100/cm.v50i4.4185]
Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, et al. Tuberculosis incidence and risk factors among human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy in a large HIV program in Nigeria. Open Forum Infectious Diseases 2015;2(4):ofv154. [DOI: 10.1093/ofid/ofv154]
Choun K, Thai S, Pe R, Lorent N, Lynen L, van Griensven J. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia. Transactions of the Royal Society of Tropical Medicine and Hygiene 2013;107(4):235-42. [DOI: 10.1093/trstmh/trt001]
Hanrahan CF, Golub JE, Mohapi L, Tshabangu N, Modisenyane T, Chaisson RE, et al. Body mass index and risk of tuberculosis and death. AIDS (London, England) 2010;24(10):1501-8. [DOI: 10.1097/QAD.0b013e32833a2a4a]
Kim SJ, Ye S, Ha E, Chun EM. Association of body mass index with incident tuberculosis in Korea. PLOS One 2018;13(4):e0195104. [DOI: 10.1371/journal.pone.0195104]
Li N, Manji KP, Spiegelman D, Muya A, Mwiru RS, Liu E, et al. Incident tuberculosis and risk factors among HIV-infected children in Tanzania. AIDS (London, England) 2013;27(8):1273-81. [DOI: 10.1097/QAD.0b013e32835ecb24]
Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS (London, England) 2015;29(11):1391-9. [DOI: 10.1097/qad.0000000000000705]
Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS (London, England) 2007;21(6):713-9. [DOI: 10.1097/QAD.0b013e328013f632]
Park HY, Choi SH, Kim D, Hwang J, Kwon Y, Kwon JW. Incidence and risk factors of tuberculosis in patients following gastrectomy or endoscopic submucosal dissection: a cohort analysis of country-level data. Gastric Cancer 2023;26(3):405-14. [DOI: 10.1007/s10120-023-01367-4]
Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. Journal of Acquired Immune Deficiency Syndromes 2011;56(4):349-55. [DOI: 10.1097/QAI.0b013e3181f9fb39]
Were W, Moore D, Ekwaru P, Mwima G, Bunnell R, Kaharuza F, et al. A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda. International Journal of Tuberculosis and Lung Disease 2009;13(1):47-53.
Yen YF, Hu HY, Lee YL, Ku PW, Lin IF, Chu D, et al. Obesity/overweight reduces the risk of active tuberculosis: a nationwide population-based cohort study in Taiwan. International Journal of Obesity 2017;41(6):971-5. [DOI: 10.1038/ijo.2017.64]
Youn HM, Shin MK, Jeong D, Kim HJ, Choi H, Kang YA. Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLOS One 2022;17(6):e0268290. [DOI: 10.1371/journal.pone.0268290]
Aibana O, Acharya X, Huang CC, Becerra MC, Galea JT, Chiang SS, et al. Nutritional status and tuberculosis risk in adult and pediatric household contacts. PLOS One 2016;11(11):e0166333. [DOI: 10.1371/journal.pone.0166333]
Anaam MS, Alrasheedy AA, Alsahali S, Alfadly SO, Aldhubhani AH. Rate and risk factors of recurrent tuberculosis in Yemen: a 5-year prospective study. Infectious Diseases (London, England) 2020;52(3):161-9. [DOI: 10.1080/23744235.2019.1690162]
Batista Jd, de Albuquerque Mde F, Maruza M, Ximenes RA, Santos ML, Montarroyos UR, et al. Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. PLOS One 2013;8(5):e63916. [DOI: 10.1371/journal.pone.0063916]
Jung WJ, Park YM, Song JH, Chung KS, Kim SY, Kim EY, et al. Risk factors for tuberculosis after gastrectomy in gastric cancer. World Journal of Gastroenterology 2016;22(8):2585-91. [DOI: 10.3748/wjg.v22.i8.2585]
Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodríguez M. Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. Journal of Acquired Immune Deficiency Syndromes 2011;57(4):311-8. [DOI: 10.1097/QAI.0b013e318218a713]
Park J, Yoon JH, Ki HK, Eun Y, Han K, Kim H. Association of duration of undernutrition with occurrence of tuberculosis. BMC Public Health 2022;22(1):2392. [DOI: 10.1186/s12889-022-14876-1]
Sudfeld CR, Isanaka S, Mugusi FM, Aboud S, Wang M, Chalamilla GE, et al. Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort. American Journal of Clinical Nutrition 2013;97(6):1278-87. [DOI: 10.3945/ajcn.112.053728]
Yoo JE, Kim D, Choi H, Kang YA, Han K, Lee H, et al. Anemia, sarcopenia, physical activity, and the risk of tuberculosis in the older population: a nationwide cohort study. Therapeutic Advances in Chronic Disease 2021;12:20406223211015959. [DOI: 10.1177/20406223211015959]
Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open 2018;8(2):e016961. [DOI: 10.1136/bmjopen-2017-016961]
Alemu A, Yesuf A, Zerihun B, Getu M, Worku T, Bitew ZW. Incidence and determinants of tuberculosis among HIV-positive individuals in Addis Ababa, Ethiopia: a retrospective cohort study. International Journal of Infectious Diseases 2020;95:59-66. [DOI: 10.1016/j.ijid.2020.02.053]
Ayana GM, Akalu TY, Ayele TA. Joint modeling of incidence of tuberculosis and change in viral load over time among adult HIV/AIDS patients on anti-retroviral therapy at Zewditu Memorial Hospital in Addis Ababa, Ethiopia. HIV/AIDS (Auckland, N.Z.) 2021;13:239-49. [DOI: 10.2147/hiv.S291872]
Beshir MT, Beyene AH, Tlaye KG, Demelew TM. Incidence and predictors of tuberculosis among HIV-positive children at Adama Referral Hospital and Medical College, Oromia, Ethiopia: a retrospective follow-up study. Epidemiology and Health 2019;41:e2019028. [DOI: 10.4178/epih.e2019028]
Chen J, Zha S, Hou J, Lu K, Qiu Y, Yang R, et al. Dose-response relationship between body mass index and tuberculosis in China: a population-based cohort study. BMJ Open 2022;12(3):e050928. [DOI: 10.1136/bmjopen-2021-050928]
Cheng J, Sun YN, Zhang CY, Yu YL, Tang LH, Peng H, et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infectious Diseases of Poverty 2020;9(1):13. [DOI: 10.1186/s40249-019-0614-9]
Cheng J, Yu Y, Ma Q, Wang Z, Zhou Q, Zhang G, et al. Prevalence, incidence, and characteristics of tuberculosis among known diabetes patients - a prospective cohort study in 10 sites, 2013-2015. China CDC Weekly 2022;4(3):41-6. [DOI: 10.46234/ccdcw2022.004]
Cho SH, Lee H, Kwon H, Shin DW, Joh HK, Han K, et al. Association of underweight status with the risk of tuberculosis: a nationwide population-based cohort study. Scientific Reports 2022;12(1):16207. [DOI: 10.1038/s41598-022-20550-8]
Choi H, Yoo JE, Han K, Choi W, Rhee SY, Lee H, et al. Body mass index, diabetes, and risk of tuberculosis: a retrospective cohort study. Frontiers in Nutrition 2021;8:739766. [DOI: 10.3389/fnut.2021.739766]
Ganesan K, Mwesigwa R, Dear N, Esber AL, Reed D, Kibuuka H, et al. Epidemiology of tuberculosis among people living with HIV in the African cohort study from 2013 to 2021. Journal of Acquired Immune Deficiency Syndromes 2023;92(5):359-69. [DOI: 10.1097/qai.0000000000003152]
Gedfew M, Ayana M, Abate A, Bewket B, Haile D, Edmealem A, et al. Incidence and predictors of tuberculosis among adult diabetic patients, Debre Markos Referral Hospital, Northwest Ethiopia, 2018: a retrospective cohort study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020;13:869-78. [DOI: 10.2147/dmso.S233564]
Gedfew M. Predictors of extrapulmonary tuberculosis among diabetic patients at Debre Markos compressive specialized hospital, Ethiopia, 2021: a retrospective cohort study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2021;25:100280. [DOI: 10.1016/j.jctube.2021.100280]
Getu A, Wolde HF, Animut Y, Kibret AA. Incidence and predictors of tuberculosis among patients enrolled in anti-retroviral therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow-up study. PLOS One 2022;17(8):e0272358. [DOI: 10.1371/journal.pone.0272358]
Kyaw NTT, Kumar AMV, Harries AD, Satyanarayana S, Oo NL, Hayat MJ, et al. Synergy between low BMI and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV. AIDS (London, England) 2022;36(1):117-25. [DOI: 10.1097/qad.0000000000003090]
Long W, Cai F, Wang X, Zheng N, Wu R. High risk of activation of latent tuberculosis infection in rheumatic disease patients. Infectious Diseases (London, England) 2020;52(2):80-6. [DOI: 10.1080/23744235.2019.1682187]
Okwara FN, Oyore JP, Were FN, Gwer S. Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study. BMC Infectious Diseases 2017;17(1):623. [DOI: 10.1186/s12879-017-2719-8]
Paradkar M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, Thiruvengadam K, Gupte AN, et al. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLOS One 2020;15(7):e0236743. [DOI: 10.1371/journal.pone.0236743]
Sabasaba A, Mwambi H, Somi G, Ramadhani A, Mahande MJ. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study. BMC Infectious Diseases 2019;19(1):62. [DOI: 10.1186/s12879-019-3696-x]
Tchakounte Youngui B, Coffie P, Messou E, Poda A, Fortes Deguenonvo L, Hawerlander D, et al. Incidence of tuberculosis during the first year of antiretroviral treatment in West African HIV-infected adults. Open Forum Infectious Diseases 2020;7(6):ofaa203. [DOI: 10.1093/ofid/ofaa203]
Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, et al. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clinical & Developmental Immunology 2011;2011:758350. [DOI: 10.1155/2011/758350]
Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No: CD000171. [DOI: 10.1002/14651858.CD000171.pub3]
Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLOS Medicine 2012;9(7):e1001270. [DOI: 10.1371/journal.pmed.1001270]
Ssentongo P, Ssentongo AE, Ba DM, Ericson JE, Na M, Gao X, et al. Global, regional and national epidemiology and prevalence of child stunting, wasting and underweight in low- and middle-income countries, 2006–2018. Scientific Reports 2021;11(1):5204. [DOI: 10.1038/s41598-021-84302-w]
Bhargava A, Bhargava M, Beneditti A, Kurpad A. Attributable is preventable: Corrected and revised estimates of population attributable fraction of TB related to undernutrition in 30 high TB burden countries. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2022;27:100309. [DOI: 10.1016/j.jctube.2022.100309]
Franco JVA, Metzendorf M-I, Risso A, Boeckmann M, Schlesinger S, Damen JAAG, et al. Undernutrition as a risk factor for tuberculosis disease. Cochrane Database of Systematic Reviews 2023, Issue 10. Art. No: CD015890. [DOI: 10.1002/14651858.CD015890]
Garegnani L, Franco JVA, Melendi SE, Vernooij RWM, Jung JH, Hwang EC, et al. Prediction of disease specific and overall survival in men with prostate cancer using the Decipher assay. Cochrane Database of Systematic Reviews 2023, Issue 3. Art. No: CD014746. [DOI: 10.1002/14651858.CD014746]
Perais J, Agarwal R, Evans JR, Loveman E, Colquitt JL, Owens D, et al. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Cochrane Database of Systematic Reviews 2023, Issue 2. Art. No: CD013775. [DOI: 10.1002/14651858.CD013775.pub2]